Results 151 to 160 of about 25,762 (279)

Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome. [PDF]

open access: yes, 2014
The alternative pathway of complement is implicated in the pathogenesis of several renal diseases, such as atypical hemolytic uremic syndrome, dense deposit disease and other forms of C3 glomerulopathy.
Józsi, Mihály   +6 more
core   +1 more source

Prepartum Eculizumab for prevention of atypical hemolytic uremic syndrome: A case report [PDF]

open access: hybrid, 2016
Gianluigi Ardissino   +8 more
openalex   +1 more source

Concurrent Atypical Hemolytic Uremic Syndrome and Autoimmune Hemolytic Anemia: a case report

open access: yesCaspian Journal of Pediatrics, 2018
Background: Atypical hemolytic uremic syndrome (aHUS) is a life-threatening and scarce disorder characterized by acute renal failure and disease, non-immune microangiopathic hemolytic anemia and thrombocytopenia, leading to end-stage renal failure or ...
Sayed Yousef Mojtahedi   +1 more
doaj  

Optimizing the Long-Term Therapy with Eculizumab (ECU) for Atypical Hemolytic Uremic Syndrome (aHUS) [PDF]

open access: bronze, 2023
Luisa Santangelo   +9 more
openalex   +1 more source

Administração profiláctica de plasma no síndrome hemolítico urémico atípico recorrente [PDF]

open access: yes, 2006
O síndrome hemolítico urémico (SHU) define- se pela ocorrência simultânea de anemia hemolítica microangiopática, trombocitopenia e insuficiência renal aguda.
Almeida, Marta Pinto de   +7 more
core  

«ADAMTS13 – VON WILLEBRAND FACTOR – PLATELETS» SYSTEM IN ATYPICAL HEMOLYTIC UREMIC SYNDROME IN CHILDREN

open access: hybrid, 2021
Х М Эмирова   +10 more
openalex   +1 more source

Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom [PDF]

open access: yes, 2010
,   +4 more
core   +1 more source

WCN23-1051 COVID-19 VACCINATION AND COVID 19 INFECTION IN ATYPICAL HEMOLYTIC UREMIC SYNDROME: ONE SINGLE CENTER STUDY IN TAIWAN

open access: gold, 2023
I.R. CHEN   +7 more
openalex   +1 more source

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

open access: yesNew England Journal of Medicine, 2013
C. Legendre   +32 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy